These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17134377)

  • 1. C-reactive protein modulates vagal heart rate control in patients with coronary artery disease.
    Nolan RP; Reid GJ; Seidelin PH; Lau HK
    Clin Sci (Lond); 2007 Apr; 112(8):449-56. PubMed ID: 17134377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.
    Aso Y; Wakabayashi S; Nakano T; Yamamoto R; Takebayashi K; Inukai T
    Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control.
    Nolan RP; Kamath MV; Floras JS; Stanley J; Pang C; Picton P; Young QR
    Am Heart J; 2005 Jun; 149(6):1137. PubMed ID: 15976804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effect of percutaneous and surgical coronary revascularization on cardiac autonomic function and inflammation in patients with stable angina.
    Santangeli P; Sgueglia GA; Sestito A; Lamendola P; Mariani L; Infusino F; Niccoli G; Crea F; Lanza GA
    Int J Cardiol; 2008 Jul; 127(2):269-70. PubMed ID: 17532490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory markers and heart rate variability in women with coronary heart disease.
    Janszky I; Ericson M; Lekander M; Blom M; Buhlin K; Georgiades A; Ahnve S
    J Intern Med; 2004 Nov; 256(5):421-8. PubMed ID: 15485478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
    Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
    Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of plasma high-sensitive C-reactive protein and monocyte chemotactic factor-1 following percutaneous coronary interventional procedures in patients with coronary artery disease].
    Wang SL; Han YL; Liu LJ; Yan CH; Kang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1073-5. PubMed ID: 18583268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris.
    Lanza GA; Sgueglia GA; Cianflone D; Rebuzzi AG; Angeloni G; Sestito A; Infusino F; Crea F; Maseri A;
    Am J Cardiol; 2006 Jun; 97(12):1702-6. PubMed ID: 16765117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of nonlinear heart rate dynamics after beating-heart revascularization.
    Ksela J; Suwalski P; Kalisnik JM; Avbelj V; Suwalski G; Gersak B
    Heart Surg Forum; 2009 Jan; 12(1):E10-6. PubMed ID: 19233759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients.
    Fabijanić D; Banić M; Kardum D; Sutlić Z; Simunić M; Bonacin D; Romić Z; Petricusić L; Kujundzić M
    Med Sci Monit; 2009 Feb; 15(2):CR45-50. PubMed ID: 19179966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Allan factor: a new model of mathematical interpretation of heart rate variability in stable coronary artery disease. Preliminary results.
    Pawlak-Buś K; Kołodziejczyk-Feliksik M; Kramer L; Nikisch E; Moczko J; Siminiak T
    Kardiol Pol; 2005 Aug; 63(2):125-32; discussion 133-5. PubMed ID: 16136410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural modification of the cholinergic anti-inflammatory response to C-reactive protein in patients with hypertension.
    Nolan RP; Floras JS; Ahmed L; Harvey PJ; Hiscock N; Hendrickx H; Talbot D
    J Intern Med; 2012 Aug; 272(2):161-9. PubMed ID: 22292421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein levels determine systemic nitric oxide bioavailability in patients with coronary artery disease.
    Fichtlscherer S; Breuer S; Schächinger V; Dimmeler S; Zeiher AM
    Eur Heart J; 2004 Aug; 25(16):1412-8. PubMed ID: 15321699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower heart rate variability is associated with higher serum high-sensitivity C-reactive protein concentration in healthy individuals aged 46 years or more.
    Araújo F; Antelmi I; Pereira AC; Latorre Mdo R; Grupi CJ; Krieger JE; Mansur AJ
    Int J Cardiol; 2006 Mar; 107(3):333-7. PubMed ID: 16503254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.